Science Friday22 Jul 2024

FDA Panel Rejects MDMA Therapy For PTSD

Last month, the first psychedelic therapy treatment came before the Food and Drug Administration for a vote. It entailed using MDMA, also known as ecstasy or molly, to treat PTSD.

MDMA therapy has looked promising as a treatment for PTSD and other mental health conditions in some studies. But the FDA scientific advisory panel that evaluated this treatment voted overwhelmingly against approving it.

Many of the arguments against approval had less to do with MDMA itself than with the methodology of the clinical trials done by Lykos Therapeutics, formerly the Multidisciplinary Association for Psychedelic Studies, or MAPS. The FDA panel was presented with allegations of misconduct and incongruous data, including a letter by trial participant Sarah McNamee.

McNamee, who joined the trial for treatment of PTSD, is also a licensed psychotherapist and researcher of trauma and psychotherapy at McGill University in Montreal. She joins guest host Rachel Feltman alongside Dr. Eiko Fried, a methodologist and psychologist at Leiden University in the Netherlands, to discuss the decision.

If you or someone you know is struggling with PTSD or other mental health conditions, call 988 for the suicide and crisis lifeline.

Transcripts for each segment will be available after the show airs on sciencefriday.com.

Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1383)

Making a case for physicists to join climate research

When you think of physics, your mind might go to forces—like gravity, friction, and magnetism—or to astrophysics, like galaxies and exoplanets. But many of the same principles used to understand how t...

20 Aug 12min

Creating 'world models' for robots + An AI math shakeup

When you ask an LLM like ChatGPT or Claude a question, the model goes through its massive amount of training data and guesses the answer by mathematically predicting the word most likely to appear nex...

19 Aug 17min

What can moments of lucidity teach us about Alzheimer’s?

Watching a loved one with Alzheimer's or dementia slowly lose their cognitive abilities can be heartbreaking. While the person you once knew seems to be slipping away, sometimes people with Alzheimer'...

18 Aug 17min

Colorado’s snow drought deals a major blow to recreation

Winter in Colorado looked very different this year. Many parts of the state experienced record-high temperatures and record-low snowpack, which had downstream effects on farming, sports, tourism, and ...

17 Aug 11min

How do you find a ‘lost’ species?

The earth is facing a biodiversity crisis, and there’s a lot of attention on species that are threatened, or at risk of dying out completely. But, there’s another critter category that’s a little more...

14 Aug 18min

What we get wrong about vaccine hesitancy

President Trump has signed an executive order calling for a change to the childhood vaccination schedule. Specifically, he wants to separate the MMR vaccine, which protects against measles, mumps, and...

13 Aug 12min

Why this lab studies the speed of bug pee and other curiosities

In a lab in the Rocky Mountains, a group of scientists is hard at work trying to find answers across biology, physics, and engineering: They’re looking into things like the hydrodynamics of insect pee...

12 Aug 18min

Some primates undergo even more extreme childbirth than humans

Human childbirth is often difficult and incredibly painful—just ask anyone who’s been through it. And for a long time, childbirth seemed to be uniquely difficult for humans. But a new study suggests t...

11 Aug 11min